BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Lin LC, Hsu TH, Huang KW, Tam KW. Nonbismuth concomitant quadruple therapy for Helicobacter pylori eradication in Chinese regions: A meta-analysis of randomized controlled trials. World J Gastroenterol 2016; 22(23): 5445-5453 [PMID: 27340362 DOI: 10.3748/wjg.v22.i23.5445]
URL: https://www.wjgnet.com/1007-9327/full/v22/i23/5445.htm
Number Citing Articles
1
Yan Sun, Jinping Zhang, Yuanyuan Chen. Efficacy and safety of Jianzhong decoction in treating peptic ulcers: a meta-analysis of 58 randomised controlled trials with 5192 patientsBMC Complementary and Alternative Medicine 2017; 17(1) doi: 10.1186/s12906-017-1723-2
2
Vasiliy Ivanovich Reshetnyak, Tatiana Magomedalievna Reshetnyak. Significance of dormant forms of <i>Helicobacter pylori</i> in ulcerogenesisWorld Journal of Gastroenterology 2017; 23(27): 4867-4878 doi: 10.3748/wjg.v23.i27.4867
3
Giuseppe Losurdo, Floriana Giorgio, Andrea Iannone, Mariabeatrice Principi, Michele Barone, Alfredo Di Leo, Enzo Ierardi. Role of concomitant therapy for <i>Helicobacter pylori</i> eradication: A technical noteWorld Journal of Gastroenterology 2016; 22(38): 8638-8640 doi: 10.3748/wjg.v22.i38.8638
4
Mei-Jyh Chen, Chien-Chuan Chen, Yen-Nien Chen, Chieh-Chang Chen, Yu-Jen Fang, Jaw-Town Lin, Ming-Shiang Wu, Jyh-Ming Liou. Systematic Review with Meta-Analysis: Concomitant Therapy vs. Triple Therapy for the First-Line Treatment of Helicobacter pylori InfectionAmerican Journal of Gastroenterology 2018; 113(10): 1444 doi: 10.1038/s41395-018-0217-2
5
Sanjeev Kumar Jha, Manish K. Mishra, Kuldeep Saharawat, Praveen Jha, Shubham Purkayastha, Ravish Ranjan. Comparison of concomitant therapy versus standard triple-drug therapy for eradication of Helicobacter pylori infection: A prospective open-label randomized controlled trialIndian Journal of Gastroenterology 2019; 38(4): 325 doi: 10.1007/s12664-019-00949-4
6
Yuwei Deng, Wenjia Su, Junwen Zhu, Hongfei Ji, Xiaoping Zhou, Jingshu Geng, Jiayu Zhu, Qingyuan Zhang. Helicobacter pylori infection disturbs the tumor immune microenvironment and is associated with a discrepant prognosis in gastric de novo diffuse large B-cell lymphomaJournal for ImmunoTherapy of Cancer 2021; 9(10): e002947 doi: 10.1136/jitc-2021-002947
7
Ju Yup Lee, Kyung Sik Park. Optimal First-Line Treatment forHelicobacter pyloriInfection: Recent StrategiesGastroenterology Research and Practice 2016; 2016: 1 doi: 10.1155/2016/9086581
8
Anthony O'Connor, Dominique Lamarque, Javier P. Gisbert, Colm O'Morain. Treatment ofHelicobacter pyloriinfection 2017Helicobacter 2017; 22: e12410 doi: 10.1111/hel.12410